RecruitingNCT05734430

Genetics of Appendix Cancer Study

Genetics of Appendix Cancer: The GAP Study

Sponsor

Andreana Holowatyj, PhD, MSCI

Enrollment

700 participants

Start Date

Nov 11, 2022

Study Type

OBSERVATIONAL

Conditions

Appendiceal Cancer Appendix Cancer Appendiceal Adenocarcinoma Appendiceal Neoplasms Appendiceal Mucinous Neoplasm Appendiceal Carcinoid Tumor Appendiceal Neoplasm Malignant Secondary Appendix Adenocarcinoma Appendix Mucinous Neoplasm Appendix Tumor Appendix Cancer Metastatic Appendix NET Low-Grade Appendix Mucinous Neoplasm High Grade Appendix Mucinous Neoplasm High Grade Appendix Mucinous Adenocarcinoma

Summary

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Genetic profiling and Retrospective tissue procurement for people with appendiceal adenocarcinoma, appendiceal cancer, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.